Dr. Mark S. Segal, MD

Dr. Segal practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Segal's NPI, 1477574085, was assigned on July 21, 2006. Dr. Segal graduated from UT Southwestern Medical Center in 1992. Dr. Segal holds Florida license ME79739.

Dr. Segal's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Segal's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Segal practices. Vendor and product names are available with a free account.

Nephrology is Dr. Segal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Segal is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Segal's licenses on file in 3 states: Florida, Massachusetts and Texas.

Dmand AI lists chronic kidney disease and kidney disease among the conditions Dr. Segal treats.

CMS data shows 105 Medicare services from Dr. Segal across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $7,293 for them. Every service was in an office.

CMS counts 50 Medicare patients who saw Dr. Segal in 2024. The largest group is under 65, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 40% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Segal's median patient age at 61, with 72% women.

In 2024, Dr. Segal wrote 987 Medicare Part D claims for 74 patients. 92% of them were for generic drugs. CMS names the drug for 798 of them, across 21 drugs with 11 or more claims each, at $275,716 in total drug cost. In 2023, CMS named 675 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Segal for performance year 2024, reported through an alternative payment model (APM). Dr. Segal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 151 papers to Dr. Segal, published from 2003 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Kidney Failure, Chronic, Cardiovascular Diseases and Hypertension. Dr. Segal has published most often in Am J Pathol. Dr. Segal's most frequent co-authors are Azra Bihorac, MD, Maria B. Grant, MD and Ashutosh Manojkumar Shukla, MD.

Dmand AI links Dr. Segal to 2 clinical trials. Conditions studied include Atherosclerosis, Hypertension and Anemia.

CMS Open Payments shows 6 general payments to Dr. Segal from 5 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $362.

Dmand AI lists 6 awards for Dr. Segal, most recently CMS Stage 1 EHR in 2013.

Dr. Segal graduated from UT Southwestern Medical Center in 1992. Dr. Segal is a member of ASN.

Dr. Segal is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.